Learn More
TARGETMOL CHEMICALS INC LORLATINIB 25MG

Supplier: TARGETMOL CHEMICALS INC T306125MG
Also available in 2 mg 5 mg 10 mg 50 mg 100 mg 1000 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Lorlatinib (PF-6463922) is an orally available ATP-competitive inhibitor of the receptor tyrosine kinases anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1) with potential antineoplastic activity. purity: 99%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.